Gianmarco Zuccon

Gianmarco Zuccon

Auto-generated profile, based on publicly available information

Gianmarco Zuccon

Vascular Division, Cardiovascular Department, HPG23 Hospital, Bergamo, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2023 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
GZGianmarco Zuccon
Gianmarco Zuccon
Mario D’OriaMario D’Oria
Mario D’Oria
FGFrederico Bastos Gonçalves
Frederico Bastos Gonçalves
CFCarlota Fernandez-Prendes
Carlota Fernandez-Prendes
KMKevin Mani
Kevin Mani
AWAnders Wanhainen
Anders Wanhainen

1 November 2020 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
CMCristina Mietto
Cristina Mietto
VSValentina Salice
Valentina Salice
MFMatteo Ferraris
Matteo Ferraris
GZGianmarco Zuccon
Gianmarco Zuccon
FVFederico Valdambrini
Federico Valdambrini
DRDanilo Radrizzani
Danilo Radrizzani

16 September 2022 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
GZGianmarco Zuccon
Gianmarco Zuccon
AWAnders Wanhainen
Anders Wanhainen
DLDavid Lindström
David Lindström
GTGustaf Tegler
Gustaf Tegler
MGMatthew Joe Grima
Matthew Joe Grima
KMKevin Mani
Kevin Mani
Purpose: The aim of this study was to present a new technique for fenestrated endovascular aortic aneurysm repair (FEVAR) and to review its preliminary results. The SiMplified bARe-wire Target vessel (SMART) technique for FEVAR aims to simplify the procedure by avoiding guiding sheaths into visceral arteries during the main graft deployment. Materials and Methods: The SMART technique requires a 12 to 16Fr contralateral introducer, depending on number of fenestrations—compared with standard 18 to 22Fr for 3 to 4 FEVAR—to achieve target vessel catheterization and stenting during FEVAR by avoiding the use of parallel 6 to 7Fr guiding sheaths into each visceral vessel. Fenestrations are sequentially catheterized, assisted by a steerable sheath. A Rosen wire is maintained in each fenestration, with a single sheath parked in the final target vessel while releasing the fenestrated graft. Data on patients treated for pararenal or thoracoabdominal aortic aneurysms with FEVAR, adopting the SMART technique, were retrospectively reviewed. End points were technical success, intraprocedural variables, 90-day mortality, major adverse events (MAEs), and target vessel patency. Results: From May 2018 to December 2020, 57 consecutive patients were treated for pararenal or thoracoabdominal aortic aneurysms. Median total procedure time and total fluoroscopy time were 223 (196–271) minutes and 81 (71–94) minutes, respectively. Primary technical success was 96.4% (55/57). No misalignment occurred from graft deployment. The total number of fenestrations was 169, including 54 left and 53 right renal arteries, 43 superior mesenteric arteries and 18 celiac trunks (3.0±0.9 vessels/patient), with target vessel technical success of 98.2%. During the first 90 days, there were no deaths (0%). The MAEs included acute kidney injury (AKI) in 3 patients (5%) with no new dialysis onset, respiratory failure requiring prolonged ventilation in 2 patients (4%), myocardial ischemia in 1 patient (2%), but no lower limb ischemia, stroke, or spinal cord ischemia (SCI) occurred. After a mean follow-up of 14±10 months, there was 1 aortic-related death. Primary and assisted primary target vessel patency was 94.6%±1.8 and 97.0%±1.3% respectively. Conclusions: The SMART technique proved to be a safe alternative to standard FEVARs, with excellent technical result and acceptable target vessel patency at mid-term, while reducing the risk for introducer-induced lower limb ischemia, related complications, and morbidity. Clinical Impact: This study evalautes the outcome of fenestrated endovascular aortic repair (FEVAR) procedures at Uppsala university hospital using a simplified bare-wire Target vessel (SMART) technique. The SMART technique requires a smaller contralateral introducer compared to standard 18-22Fr for 3-4 FEVAR to achieve target vessel catetherization and stenting. Fifty-seven consecutive patients were treated for pararenal or thoracoabdominal aortic aneurysms. The SMART technique proved to be a safe alternative to standard FEVARs with excellent technical result and acceptable target vessel patency at mid-term, while reducing the risk for introducer-induced lower limb ischemia, related complications, and morbidity.

25 July 2023 in International Journal of Angiology
Verified
Journal Article
Closed access
PDF file
NMNicola Monzio-Compagnoni
Nicola Monzio-Compagnoni
GZGianmarco Zuccon
Gianmarco Zuccon
FBFabiane Barbosa
Fabiane Barbosa
ARAntonio Gaetano Rampoldi
Antonio Gaetano Rampoldi
VTValerio Stefano Tolva
Valerio Stefano Tolva
Type 2 endoleak has been proved not to significantly increase the risk of aneurysm rupture. However, it is associated with aneurysm enlargement and may require secondary interventions. Its role has been widely investigated, but a definitive consensus about its management has still not been obtained. We performed a retrospective, single-center observational study that investigates the incidence of type 2 endoleak and its implications in the long-term follow-up in all the patients who underwent endovascular aortic repair (EVAR) for abdominal aortic aneurysm from 2011 to 2016 at our institution. A total of 216 patients who underwent EVAR during the specified time period were enrolled, and 85 of them (39%) developed type 2 endoleak in their follow-up. Thirty-one of the patients who developed type 2 endoleak faced an aneurysm sac growth > 10 mm and required secondary intervention. Only nine of them showed resolution of the leak. In the long-term follow-up, patients who developed type 2 endoleak after EVAR did not show a significantly increased mortality compared with those who did not, but some of them required late open conversion due to aneurysm sac enlargement and some other developed a secondary type 1 endoleak which required correction. The management of type 2 endoleak remains debated, despite consensus exist regarding the need for intervention when a > 10-mm aneurysm sac growth is observed. Further studies are necessary to better define which are the “high-risk” type 2 endoleaks and identify the patients who would benefit more from correction.

10 August 2023 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
MDMario D’oRia
Mario D’oRia
GZGianmarco Zuccon
Gianmarco Zuccon
AWAnders Wanhainen
Anders Wanhainen

19 October 2023 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
GZG. Zuccon
G. Zuccon
MDM. D’ORia
M. D’ORia
FGF.B. Gonçalves
F.B. Gonçalves
CFC. Fernandez-Prendes
C. Fernandez-Prendes
KMK. Mani
K. Mani
AWAnders Wanhainen
Anders Wanhainen